Financial Statements
Financial Statements

Bayer Group Consolidated Statements of Cash Flows

 [Table 22]
 3rd Quarter 20103rd Quarter 2011First Nine Months 2010First Nine Months 2011
 € million€ million€ million€ million
Income after taxes2906461,4512,075
Income taxes7229456837
Non-operating result267224772608
Income taxes paid or accrued(106)(210)(925)(885)
Depreciation, amortization and impairments6646322,0971,983
Change in pension provisions(225)(181)(459)(431)
(Gains) losses on retirements of noncurrent assets(10)(13)(35)(19)
Gross cash flow8871,3273,3574,168
     
Decrease (increase) in inventories(112)(192)(42)(524)
Decrease (increase) in trade accounts receivable505571(394)(500)
(Decrease) increase in trade accounts payable(168)(157)32(83)
Changes in other working capital, other non-cash items44328879847
Net cash provided by (used in) operating activities (net cash flow)1,5551,5773,8323,908
     
Cash outflows for additions to property, plant, equipment and intangible assets(395)(354)(990)(890)
Cash inflows from sales of property, plant, equipment and other assets15244089
Cash inflows from divestitures36287780
Cash inflows from (outflows for) noncurrent financial assets(209)16(452)(54)
Cash outflows for acquisitions less acquired cash(1)(87)(18)(235)
Interest and dividends received15134841
Cash inflows from (outflows for) current financial assets(100)(1,277)(83)(2,208)
Net cash provided by (used in) investing activities(639)(1,637)(1,378)(3,177)
     
Dividend payments and withholding tax on dividends(1)(2)(1,159)(1,243)
Issuances of debt22247713505
Retirements of debt(1,339)(419)(2,110)(1,112)
Interest paid including interest rate swaps(254)(268)(773)(741)
Interest received from interest rate swaps9677325269
Cash outflows for the purchase of additional interests in subsidiaries(5)(2)(6)(4)
Net cash provided by (used in) financing activities(1,281)(567)(3,010)(2,326)
     
Change in cash and cash equivalents due to business activities(365)(627)(556)(1,595)
     
Cash and cash equivalents at beginning of period2,5511,7972,7252,840
     
Change in cash and cash equivalents due to exchange rate movements(62)11(45)(64)
     
Cash and cash equivalents at end of period2,1241,1812,1241,181
2010 figures restated
Last updated: October 27, 2011

http://www.stockholders-newsletter-q3-2011.bayer.com/en/statements-of-cash-flows.aspx

Copyright © Bayer AG

Print page

Search

Download Center

Publications

Services

Special Interest